Page 285 - Read Online

Magee et al. Egr1 in liver metabolism and cancer

caveolin-1 promoter activity. J Biol Chem 1999;274:32333-41. through EGFR signaling pathway. Oncotarget 2016;7:45302-16.
85. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling 93. Lee KH, Kim JR. Hepatocyte growth factor induced up-regulations
pathways in cancer. Oncogene 2007;26:3279-90. of VEGF through Egr-1 in hepatocellular carcinoma cells. Clin Exp
86. Berger E, Vega N, Vidal H, Geloen A. Gene network analysis leads Metastasis 2009;26:685-92.
to functional validation of pathways linked to cancer cell growth and 94. Archer KJ, Mas VR, David K, Maluf DG, Bornstein K, Fisher RA.
survival. Biotechnol J 2012;7:1395-404. Identifying genes for establishing a multigenic test for hepatocellular
87. Yang W, Zhao JG, Li XY, Gong SL, Cao JP. Anti-tumor effect of carcinoma surveillance in hepatitis C virus-positive cirrhotic patients.
125I-UdR in combination with Egr-1 promoter-based IFNgamma Cancer Epidemiol Biomarkers Prev 2009;18:2929-32.
gene therapy in vivo. Radiat Environ Biophys 2010;49:705-14. 95. Ma Y, Han CC, Huang Q, Sun WY, Wei W. GRK2 overexpression
88. Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX. Transcription inhibits IGF1-induced proliferation and migration of human
factor EGR-1 inhibits growth of hepatocellular carcinoma and hepatocellular carcinoma cells by downregulating EGR1. Oncol Rep
esophageal carcinoma cell lines. World J Gastroenterol 2002;8:203-7. 2016;35:3068-74.
89. Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park 96. Peng WX, Pan FY, Liu XJ, Ning S, Xu N, Meng FL, Wang YQ, Li
YC, Suh H, Kim GY, Choi YH, Kim ND. A chenodeoxycholic CJ. Hypoxia stabilizes microtubule networks and decreases tumor
derivative, HS-1200, induces apoptosis and cell cycle modulation via cell chemosensitivity to anticancer drugs through Egr-1. Anat Rec
Egr-1 gene expression control on human hepatoma cells. Cancer Lett (Hoboken) 2010;293:414-20.
2008;270:77-86. 97. Chang Y, Yan W, He X, Zhang L, Li C, Huang H, Nace G, Geller
90. Yu J, Zhang SS, Saito K, Williams S, Arimura Y, Ma Y, Ke Y, Baron DA, Lin J, Tsung A. miR-375 inhibits autophagy and reduces
V, Mercola D, Feng GS, Adamson E, Mustelin T. PTEN regulation by viability of hepatocellular carcinoma cells under hypoxic conditions.
Akt-EGR1-ARF-PTEN axis. EMBO J 2009;28:21-33. Gastroenterology 2012;143:177-87.e8.
91. Tian H, Ge C, Li H, Zhao F, Hou H, Chen T, Jiang G, Xie H, Cui Y, 98. Toshima T, Shirabe K, Matsumoto Y, Yoshiya S, Ikegami T,
Yao M, Li J. Ribonucleotide reductase M2B inhibits cell migration and Yoshizumi T, Soejima Y, Ikeda T, Maehara Y. Autophagy enhances
spreading by early growth response protein 1-mediated phosphatase hepatocellular carcinoma progression by activation of mitochondrial
and tensin homolog/Akt1 pathway in hepatocellular carcinoma. beta-oxidation. J Gastroenterol 2014;49:907-16.
Hepatology 2014;59:1459-70. 99. Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang
92. Wang L, Sun H, Wang X, Hou N, Zhao L, Tong D, He K, Yang Y, SS, Deng WJ, Zhao X, Wu MC, Wei LX. Inhibition of autophagy
Song T, Yang J, Huang C. EGR1 mediates miR-203a suppress the enhances anticancer effects of bevacizumab in hepatocarcinoma. J
hepatocellular carcinoma cells progression by targeting HOXD3 Mol Med (Berl) 2013;91:473-83.

Hepatoma Research ¦ Volume 3 ¦ November 20, 2017 277